📣ESMO #ClinicalPracticeGuideline on #UvealMelanoma:

✨Percutaneous hepatic perfusion & tebentafusp: metastatic disease Tx options
✨Key algorithms & recommendations reflecting latest clinical data

🔗 https://ow.ly/u7GU50YC8RR

#Melanoma #Oncology #ESMOGuidelines

📣 ESMO Oncogene-addicted mNSCLC Living Guideline v1.3 update: New algorithms and recommendations for c-Met overexpression, NRG1 gene fusion, EGFR mutations and HER2 alterations.

🔗 https://ow.ly/82yx50YmhtR

#ClinicalPracticeGuideline

➡️ New ESMO Living Guideline on Local and Locoregional Prostate Cancer. Consult all recommendations & algorithms from the recent #ClinicalPracticeGuideline in an interactive format, also mobile friendly.
🔗 https://ow.ly/zi8P50YhZy5

📣ESMO #ClinicalPracticeGuideline on #Lymphomas - New Living Guideline recommendations in the relapsed/refractory setting:
- Epcoritamab combinations and odronextamab in Follicular Lymphoma
- Sonrotoclax in Mantle Cell Lymphoma thrid-line or later

🔗 https://ow.ly/v7Uo50YcbSE

📣Updated ESMO #ClinicalPracticeGuideline on advanced and metastatic #ProstateCancer:
✅ Substantial advances in castration-sensitive & -resistant prostate cancer
✅ Updated algorithms & recommendations reflecting latest clinical data
#ESMOGuidelines Christopher Sweeney

🔗 https://ow.ly/E4ov50Yc8e2

@cancersociety.bsky.social -funded research is changing how people with #cancer are treated worldwide. We’re proud to see @myesmo.bsky.social #ClinicalPracticeGuideline update recommending structured exercise for people with #ColonCancer.

Learn more about this @cctg.bsky.social trial: is.gd/ojV6cY

📣ESMO #ClinicalPracticeGuideline Express Update on #EpithelialOvarianCancer:
- Rucaparib: 1st-line PARPi maintenance option
- MIRV: for recurrent FRα-high #OvarianCancer after 1-3 prior therapies & PFI <6 months

🔗 https://ow.ly/J06u50Y4HT8

#GYNOnc #Oncology #ESMOGuidelines

📣 ESMO #ClinicalPracticeGuideline Express Update on Localised #ColonCancer: 💡CHALLENGE trial suggests survival benefits from structured exercise
👥Selected resected patients to be informed & encouraged to participate #Oncology #ESMOGuidelines

🔗 https://ow.ly/lJY850Y49fR

Level of Evidence and Strength of Recommendations in US Medical Society Clinical Practice Guidelines, 2019-2023: A Cross-Sectional Analysis - PubMed Among recently issued CPG recommendations, overall SOR-LOE rating concordance was moderate, although recommendations with strong SOR ratings had minimal rating concordance. CPG authors could provide clearer rationales for strong recommendations when the corresponding evidence does not reflect commen …

Just published exploration of US Medical Society #ClinicalPracticeGuideline over 5 years documented epidemic of discordant #recommendation meaning strong recommendations despite low certainty #evidence. Big problem needs addressing.

pubmed.ncbi.nlm.nih.gov/41428154/

📣 Updated ESMO #ClinicalPracticeGuideline on local & locoregional #ProstateCancer:
✅New imaging modalities: Improved diagnosis, staging & risk stratification
✅Updated algorithms: less over-Tx & fewer side-effects
#Oncology #UroOncology #CancerCare #ESMOGuidelines

🔗 https://ow.ly/jwA650XLs1q

New Living Guideline on Early & Locally Advanced #NSCLC! This dynamic resource integrates all recommendations and algorithms from the recently updated #ClinicalPracticeGuideline, supporting clinicians in evidence-based decision-making for optimal patient care.

🔗 https://ow.ly/3Apq50XA60u

📣 New ESMO #Lymphomas Living Guideline v1.0.
Includes all recommendations and algorithms from the published #ClinicalPracticeGuideline, covering major lymphoma subtypes in an interactive format.

🔗 https://ow.ly/wLFE50X7y9e

#ESMOGuidelines

📣 Updated ESMO #ClinicalPracticeGuideline on early & locally advanced #NSCLC: new systemic treatments, innovative strategies & advanced therapeutic options to personalise #PatientCare & improve outcomes.

🔗 buff.ly/Yn640wo

#LungCancer #SystemicTherapy #Oncology #CancerTreatment #ESMOGuidelines

📣Updated ESMO #ClinicalPracticeGuideline recommendations in #MetastaticBreastCancer: focusing on #PrecisionOncology and a #PatientCentricCare, this commentary highlights key updates of the ESMO Living Guideline algorithms, focusing on HR+/HER2- disease. #ESMOGuidelines

🔗 buff.ly/fvvPb26

📣 New ESMO #ClinicalPracticeGuideline on #lymphomas: evidence-based recommendations for all major #lymphoma subtypes, updated as needed as an ESMO Living Guideline, reflecting developments in Tx.
#DLBCL #PCNSL #FollicularLymphoma #HodgkinLymphoma #ESMOGuidelines

🔗 buff.ly/2ZYJc2c

A Core Set of Outcome Measures to Assess Physical Function for Adults Participating in Physical Therapist Treatment in the Hospital: A Clinical Practice Guideline ABSTRACTImportance. Outcome measures (OMs) are an integral part of physical therapist practice and implementation can have a multifaceted effect on care de

Have you seen the new #AcuteCare #ClinicalPracticeGuideline??

academic.oup.com/ptj/article/...

@aptaofficial.bsky.social #CPG

📣Updated ESMO #ClinicalPracticeGuideline recommendations in oncogene-addicted metastatic #NSCLC: more #TargetedTherapy agents now available in 1L or at resistance.
#LungCancer #mNSCLC #ESMOGuidelines

🔗 buff.ly/DSLyGib

📣Updated ESMO #ClinicalPracticeGuideline recommendations in the non-oncogene-addicted metastatic #NSCLC: new 1L Tx options approved.

🔗 buff.ly/da21Bml

#LungCancer #mNSCLC #ESMOGuidelines

📣 Updated ESMO #ClinicalPracticeGuideline on #localised #rectalcancer: situation-dependent intensification & de-intensification, complex radiological factors, #biomarkers & selective Tx goals via organ-preserving strategies form options & decisions
#ESMOGuidelines
🔗 buff.ly/GPnKSMY

📣 Updated ESMO-EHA #ClinicalPracticeGuideline on management of ‘mature’ or ‘peripheral’ T- and NK-cell #lymphomas: 👉 clinical features, histopathological diagnosis, imaging, staging and risk assessment, treatment and follow-up.
🔗 buff.ly/dvDOsNK
@hemasphere-journal.bsky.social #ESMOGuidelines

🆕Brand new online! #EHA & #ESMO collaborated to bring you this #ClinicalPracticeGuideline on #PTCL. We warmly invite you to read & share with your contacts 👉 bit.ly/PTCL_GL

@myesmo.bsky.social #EHAGuidelines #ESMOGuidelines

📣 ESMO Living Guideline on Hepatocellular Carcinoma:

👉 New title with the latest recommendations and algorithms in an interactive format.

@ducreuxmichel.bsky.social
@arndtvogel.bsky.social

#ClinicalPracticeGuideline

🔗 buff.ly/ncdmYZ5

👉 Access the core content of the Living Guideline in a user-friendly format ready for you to use in your own presentations.

🔗 buff.ly/vsxcCaD

#ClinicalPracticeGuideline

📣ESMO Living Guidelines on Metastatic Breast Cancer:
👉Just updated with the latest recommendations and algorithms in an interactive format.

🔗 buff.ly/JsHALyN

#ClinicalPracticeGuideline

📣ESMO #ClinicalPracticeGuideline Express Update on #PancreaticCancer: updated 1st- & #2nd-line treatment recommendations for managing #MetastaticPancreaticCancer, following approval of 1st-line nanoliposomal #irinotecan. #ESMOGuidelines

🔗https://buff.ly/Mybc2Nq

@ducreuxmichel.bsky.social

Commonly used interventional procedures for non-cancer chronic spine pain: a clinical practice guideline - PubMed These recommendations apply to people living with chronic spine pain (≥3 months duration) that is not associated with cancer or inflammatory arthropathy and do not apply to the management of acute spi...

#Newpub in @bmj.com by @cuphysmed.bsky.social faculty Dr. Jason Friedrich & team on Commonly used interventional procedures for non-cancer chronic #spinepain: a #clinicalpracticeguideline. pubmed.ncbi.nlm.nih.gov/39971339/

#KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease ( #ADPKD): executive summary

doi.org/10.1016/j.kint.2024.07.010

#OpenAccess #clinicalpracticeguideline #kidney

Five papers suggested by Arndt Vogel - OncoDaily Five papers suggested by Arndt Vogel / Amanda L. Blackford, Arndt Vogel, Biliary tract cancer, cancer, cholangiocarcinoma, Daniel Q. Huang, ESMO Clinical

Five papers suggested by Arndt Vogel
@arndtvogel.bsky.social

oncodaily.com/science/arnd...

#BiliarytractCancer #Cancer #Cholangiocarcinoma #ESMO #ClinicalPracticeGuideline #HepatocellularCarcinoma #OncoDaily #Oncology #PancreaticCancer